查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1864632

PLGA市場按應用、產品類型、成分、分子量、給藥途徑和最終用途分類－2025-2032年全球預測

PLGA Market by Application, Product Type, Composition Ratio, Molecular Weight, Delivery Route, End Use - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，PLGA 市場將成長至 4.452 億美元，複合年成長率為 10.67%。

關鍵市場統計數據
基準年 2024 1.9781億美元
預計年份：2025年 2.1938億美元
預測年份 2032 4.452億美元
複合年成長率 (%) 10.67%

權威地介紹PLGA的技術優勢、相關人員用例和分析範圍，以明確和指導策略決策。

聚乳酸-羥基乙酸共聚物（PLGA）在聚合物科學和轉化醫學的交叉領域佔據核心地位，是治療方法和醫療設備平台的基礎生物材料。本文概述了PLGA的功能特性——生物相容性、可調控的分解速率和多樣化的加工方法——並將其置於更廣泛的生物醫學創新發展軌跡中。透過闡明本文的分析範圍和目的，讀者可以系統地了解影響PLGA應用的技術、監管和商業性因素。

製造技術、配方科學的進步以及不斷變化的臨床需求，正在從根本上重塑PLGA的開發路徑和商業化策略。

PLGA基解決方案的格局正經歷著變革性的轉變，這主要得益於技術進步、法規的演變以及臨床需求的改變。奈米沉澱和微流體控制造技術的創新使得更均勻的粒徑分佈和複雜生物製藥的可擴展封裝成為可能，從而拓展了靶向遞送和緩釋的應用前景。同時，對聚合物組成（尤其是乳酸和乙醇酸單體比例及分子量之間的相互作用）影響的深入理解，也提高了針對不同臨床應用客製化分解速率特性的能力。

針對美國不斷變化的關稅趨勢，企業應採取切實可行的營運和戰略應對措施，並調整其採購、製造和監管計劃。

美國新關稅的實施為企業在製定供應鏈規劃和籌資策略時帶來了新的營運挑戰。關稅會影響上游原料採購、進口成品的成本結構以及外包和本地化生產的經濟效益。這要求企業重新評估其供應商組合，考慮其他採購區域，並評估近岸外包和回流生產，作為降低貿易政策波動風險的手段。

將應用、產品類型、配方比例、分子量區間、給藥途徑和最終用途優先事項等詳細細分資訊與策略發展指南聯繫起來

細分市場洞察揭示了驅動產品定位和研發重點的獨特技術和商業性促進因素。在循環系統器械、緩釋和靶向藥物遞送系統、眼科器械、整形外科植入和組織工程構建體等應用領域，開發人員會根據生物界面和功能需求，優先考慮不同的聚合物特性和加工過程。例如，心血管和整形外科應用通常需要具有明確機械完整性和可預測分解特性的植入和薄膜，而藥物遞送專案則專注於針對可控藥物動力學最佳化的微球、奈米顆粒和縫線。

區域比較分析，重點關注美洲、歐洲、中東和非洲以及亞太地區在監管、製造和商業化方面的差異

區域趨勢正在影響PLGA基創新產品的開發、監管和商業化方式，美洲、歐洲、中東和非洲以及亞太地區都面臨著各自獨特的機會和挑戰。在美洲，完善的監管體系和對生物醫學研發的大力投入，為先進的臨床項目和新型給藥系統的早期應用提供了支持，同時也強調了嚴格的品質系統和臨床證據的生成。面向該地區的製造商通常會優先考慮穩健的監管策略和與支付方的合作，以支持臨床應用。

PLGA生態系統中主導企業的營運和競爭特徵，以及指南合作和投資決策的因素。

PLGA生態系統中的公司層面發展趨勢呈現出多元化的格局，既有成熟的聚合物製造商，也有專業的合約研發生產機構（CDMO），以及專注於先進配方和遞送平台的新興技術公司。現有企業通常利用其完善的品質系統和強大的生產能力服務於醫療設備和製藥客戶，而專業供應商則憑藉其在奈米顆粒工程、微囊化技術或支架製造方面的專長脫穎而出。

採取切實可行的營運和策略措施，加速PLGA的臨床應用，減少監管摩擦，並增強供應鏈韌性。

產業領導者應採取一系列切實可行的措施，將自身的技術優勢轉化為永續的競爭優勢。首先，他們應投資於能夠處理從微球、薄膜到植入等多種產品類型的靈活製造平台，從而實現計劃間的快速切換並運轉率。在進行製造投資的同時，他們還應實施嚴格的品質源於設計 (QbD) 實踐，將關鍵材料特性和加工參數規範化，從而降低下游監管風險並加快產品合格。

我們採用透明的混合方法研究方法，結合專家訪談、技術評估比較和嚴格的二次檢驗，以確保研究結果的可靠性。

本研究採用混合方法，結合了對材料科學家、配方專家、法規專家和供應鏈管理人員的訪談，以及對同行評審文獻、專利申請、法規指南和已發布的技術標準的二次分析。主要研究旨在捕捉PLGA解決方案規模化生產中的實際限制，包括生產差異、滅菌對聚合物完整性的影響以及各司法管轄區的法規證據要件。二級資訊來源提供了配方科學進展、製程創新和臨床應用模式的縱向觀點。

總之，該審查強調了技術、營運和監管的綜合方法，這將決定PLGA創新能否成功實用化。

總之，PLGA仍然是一種具有重要策略意義的生物材料，在醫療器材和給藥系統中有著廣泛的應用前景。其未來的重要性將取決於研發人員能否將材料科學的進步、可擴展的生產流程以及積極的監管策略整合起來。組成比例、分子量、產品形態和給藥途徑之間的相互作用，為企業提供了豐富的設計空間，企業可以利用這一空間來滿足各種臨床需求，前提是他們能夠將技術選擇與營運能力和區域商業化實際情況相結合。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 利用PLGA微球建構緩釋注射藥物傳遞平台
  • 拓展基於PLGA的生物可分解支架技術在骨組織再生的應用
  • 開發用於標靶腫瘤治療的個人化PLGA奈米顆粒製劑
  • 採用連續製造技術實現PLG​​A聚合物的可擴展生產
  • 將PLGA和3D列印技術結合，用於製造患者特異性可吸收植入
  • 明確監管途徑，加速PLGA藥物-醫療設備複合物的核准
  • 生物基單體來源提高了永續性，從而能夠生產更環保的PLGA聚合物。
  • PLGA表面改質在改善再生醫學中細胞黏附的進展
  • PLGA封裝系統的出現提高了mRNA疫苗的遞送效率和穩定性
  • 契約製造製造商與製藥公司就PLGA遞送解決方案建立策略聯盟

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 PLGA市場：按應用領域分類

  • 心血管器械
  • 藥物輸送
    • 緩釋性
    • 緩釋
    • 精準投放
  • 眼科器械
  • 整形外科植入
  • 組織工程

9. PLGA市場依產品類型分類

  • 電影
  • 植入
  • 微球
  • 奈米顆粒
  • 縫合線

第10章 PLGA市場：以組成比例分類

  • 50：50
  • 65：35
  • 75：25

第11章 PLGA市場：以分子量分類

  • 高分子量
  • 低分子量
  • 中等分子量

12. 按配送路線分類的PLGA市場

  • 植入式
  • 注射
  • 口服
  • 外用

第13章 PLGA市場：依最終用途分類

  • 醫療設備
  • 製藥
  • 獸醫

第14章 PLGA市集區域概覽

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 PLGA市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 PLGA市場（按國家分類）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Evonik Nutrition & Care GmbH
    • Corbion NV
    • JRS PHARMA GmbH & Co. KG
    • Jiangsu Huash Biosciences Co., Ltd.
    • Akina, Inc.
    • IMS Biotechnology Co., Ltd.
    • Shenzhen Shelinsen Biotechnology Co., Ltd.
    • Zhejiang Sobit Biotechnology Co., Ltd.
    • Feyeo Biotechnology Co., Ltd.
Product Code: MRR-7A22CB0E5B8A

The PLGA Market is projected to grow by USD 445.20 million at a CAGR of 10.67% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 197.81 million
Estimated Year [2025] USD 219.38 million
Forecast Year [2032] USD 445.20 million
CAGR (%) 10.67%

An authoritative introduction that clarifies PLGA's technical strengths, stakeholder use cases, and analytical scope to orient strategic decision making

Polylactic-co-glycolic acid (PLGA) occupies a pivotal position at the intersection of polymer science and translational medicine, serving as a foundational biomaterial across therapeutic and device platforms. This introduction frames PLGA's functional attributes-biocompatibility, tunable degradation kinetics, and versatile processing pathways-and situates those properties within the broader trajectory of biomedical innovation. By clarifying the scope and objectives of the present analysis, readers gain a structured entry point to the technical, regulatory, and commercial vectors that shape PLGA applications.

The report synthesizes cross-disciplinary evidence to illuminate how material scientists, formulation scientists, and device engineers leverage composition ratio and molecular weight to tune release profiles and mechanical performance. It also highlights how delivery route considerations-from implantable constructs to injectable microspheres and topical systems-interact with end-use environments such as medical devices, pharmaceuticals, and veterinary applications. Furthermore, this section articulates the intended audience and the decision contexts that benefit from the research findings, including product development teams, supply chain strategists, and business development leaders.

Finally, it delineates methodological boundaries and clarifies the analytical lenses employed to evaluate technology transfer, regulatory pathways, and commercialization dynamics, thereby equipping stakeholders with a clear understanding of how the subsequent sections will translate technical nuance into actionable intelligence.

How manufacturing advancements, composition science, and evolving clinical demand are fundamentally reshaping PLGA development pathways and commercialization strategies

The landscape for PLGA-based solutions is undergoing transformative shifts driven by technological advances, regulatory evolution, and changing clinical needs. Innovations in nanoprecipitation and microfluidic manufacturing are enabling more consistent particle size distributions and scalable encapsulation of complex biologics, which in turn expand the feasibility of targeted delivery and sustained release profiles. Concurrently, improved understanding of polymer composition impacts-specifically the interplay between lactic and glycolic monomer ratios and molecular weight-has enhanced the ability to tailor degradation kinetics for diverse clinical applications.

Beyond processing, shifts in clinical demand are redefining application priorities. Regenerative medicine and tissue engineering are elevating modular scaffold approaches that integrate PLGA films and implants with bioactive cues, while drug delivery programs increasingly prioritize controlled release systems and targeted delivery vehicles to reduce dosing frequency and enhance therapeutic index. These technological and clinical trends intersect with commercial dynamics: manufacturers are pursuing integrated product-device strategies and strategic partnerships to accelerate translation from bench to bedside.

Regulatory and reimbursement pathways are also maturing, prompting more robust preclinical models and longer-term biocompatibility evaluations. As a result, organizations that invest in scalable manufacturing platforms, robust quality systems, and early regulatory engagement are better positioned to capitalize on these transformative shifts and to convert technical promise into clinically effective, commercially viable solutions.

Practical operational and strategic responses to changed US tariff dynamics and how organizations must adapt sourcing, manufacturing, and regulatory plans

The imposition of new tariff measures in the United States introduces an additional operational dimension that companies must address when planning supply chains and procurement strategies. Tariffs affect upstream raw material sourcing, the cost structure of imported finished products, and the economics of outsourcing manufacturing versus localizing production. As a consequence, firms must reassess supplier portfolios, consider alternative sourcing geographies, and evaluate nearshoring or reshoring as mechanisms to mitigate exposure to trade policy volatility.

Practically, the tariffs accelerate conversations about vertical integration and long-term contracts with polymer producers to stabilize input availability and pricing. They also heighten the importance of supply chain visibility and scenario planning: organizations are increasingly mapping dependencies for critical intermediates, identifying single-source risks, and stress-testing logistics pathways. In parallel, development teams must consider formulation and design choices that reduce reliance on tariff-exposed components, and procurement teams should leverage multi-sourcing strategies to sustain continuity.

Regulatory and commercial timelines may be indirectly affected because shifts in sourcing or manufacturing footprint can require supplementary qualification work and amended regulatory filings. Therefore, coordinated cross-functional response plans-aligning procurement, quality, regulatory, and commercial functions-are essential to preserve development trajectories and to maintain access to key markets under changing trade conditions.

Detailed segmentation intelligence linking applications, product types, composition ratios, molecular weight tiers, delivery routes, and end-use priorities into strategic development guidance

Segmentation insights reveal distinct technical and commercial levers that determine product positioning and development priorities. Across application spaces such as cardiovascular devices, drug delivery systems that include controlled release, sustained release, and targeted delivery, ophthalmic devices, orthopedic implants, and tissue engineering constructs, developers prioritize different polymer characteristics and processing routes according to biological interfaces and functional demands. For example, cardiovascular and orthopedic applications frequently demand implants and films with defined mechanical integrity and predictable degradation, whereas drug delivery programs emphasize microspheres, nanoparticles, and sutures optimized for pharmacokinetic control.

Product type considerations-ranging from films and implants to microspheres, nanoparticles, and sutures-interact with composition ratio choices such as 50:50, 65:35, and 75:25 to determine degradation rates and mechanical behavior. Molecular weight selections of high, medium, or low further modulate these properties, enabling tailored solutions for specific delivery routes including implantable devices, injectable formulations, oral dosage forms, and topical applications. End-use contexts spanning medical devices, pharmaceutical pipelines, and veterinary applications impose unique regulatory expectations and lifecycle management priorities that drive formulation strategies and commercialization pathways.

Taken together, segmentation analysis underscores the importance of aligning composition and molecular design with both functional requirements and regulatory pathways. Transitioning efficiently from prototyping to clinical validation requires deliberate choices about which application and product type combinations offer the most favorable technical fit and operational feasibility, and those choices should be informed by cross-functional feasibility assessments early in development.

Comparative regional intelligence exposing regulatory, manufacturing, and commercialization distinctions across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics shape how PLGA-based innovations are developed, regulated, and commercialized, with distinct opportunities and constraints across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, a well-established regulatory infrastructure and strong investment in biomedical R&D support advanced clinical programs and early adoption of novel delivery systems, while also emphasizing rigorous quality systems and clinical evidence generation. Manufacturers targeting this region often prioritize robust regulatory strategy and payer engagement to support clinical adoption.

In Europe Middle East & Africa, regulatory heterogeneity and evolving harmonization efforts necessitate nuanced market entry strategies. Developers benefit from aligning early with notified bodies and regional clinical centers of excellence to streamline approvals and to generate the clinical evidence local stakeholders require. The Asia-Pacific region presents a diverse set of dynamics: rapid manufacturing capacity expansion, competitive contract development and manufacturing organizations, and active government initiatives to support life sciences innovation. This region can be particularly attractive for scaling production and for cost-efficient development pathways, though companies must navigate varied regulatory timelines and local clinical expectations.

Across regions, differences in reimbursement frameworks, clinical practice patterns, and supply chain infrastructure influence commercialization sequencing. Consequently, strategic planning should incorporate region-specific regulatory engagement, manufacturing footprint decisions, and targeted clinical partnerships to optimize product rollout and long-term adoption.

Operational and competitive attributes that differentiate leading organizations within the PLGA ecosystem and guide partnership and investment decisions

Company-level dynamics in the PLGA ecosystem reflect a mix of incumbent polymer manufacturers, specialized contract development and manufacturing organizations, and emerging technology firms that focus on advanced formulation and delivery platforms. Incumbents typically leverage established quality systems and broad manufacturing capacity to serve medical device and pharmaceutical clients, while specialized providers differentiate through expertise in nanoparticle engineering, microencapsulation techniques, or scaffold fabrication.

Strategic behaviors of leading players include forging partnerships with academic centers to access novel polymer chemistries, investing in proprietary processing capabilities to reduce batch variability, and expanding service portfolios to cover formulation development through regulatory filing support. Competitive advantage often accrues to organizations that combine deep materials science capabilities with flexible, scalable manufacturing and a demonstrable track record in regulatory filings across multiple jurisdictions. Smaller innovators, meanwhile, frequently focus on niche therapeutic areas or unique delivery routes where PLGA's properties can deliver clear clinical advantages.

For stakeholders evaluating potential partners or acquisition targets, due diligence should emphasize process reproducibility, quality management maturity, intellectual property around polymer formulations and processing methods, and the ability to provide clinical-grade materials. These operational attributes frequently determine the pace at which lab-scale innovations are translated into regulated products.

Actionable operational and strategic initiatives for leaders to accelerate PLGA translation, reduce regulatory friction, and strengthen supply chain resilience

Industry leaders should pursue a set of actionable initiatives to convert technical strengths into sustainable competitive advantage. First, invest in flexible manufacturing platforms that accommodate a range of product types from microspheres to films and implants, enabling faster pivoting between projects and improved capacity utilization. Complement manufacturing investments with rigorous quality-by-design practices that codify critical material attributes and processing parameters, thereby reducing downstream regulatory risk and accelerating product qualification.

Second, integrate composition and molecular weight optimization into early-stage development workflows to ensure that degradation profiles and mechanical properties are matched to clinical objectives. Cross-functional teams that align formulation scientists with clinical and regulatory experts can shorten development cycles and enhance the robustness of regulatory submissions. Third, diversify supply chains through regional partnerships and multi-sourcing arrangements to mitigate exposure to trade policy shifts and to take advantage of regional manufacturing strengths.

Finally, pursue strategic collaborations with clinical centers and technology partners to build real-world evidence and to de-risk advanced applications. These steps, taken together, will help organizations translate PLGA's intrinsic material advantages into differentiated products with viable commercialization pathways.

A transparent mixed-methods research design combining primary expert interviews, technical comparative assessments, and rigorous secondary validations to ensure robust insights

This research employs a mixed-methods approach combining primary interviews with material scientists, formulation experts, regulatory specialists, and supply chain managers, together with secondary analysis of peer-reviewed literature, patent filings, regulatory guidance, and public technical standards. Primary engagements were structured to capture practical constraints in scaling PLGA solutions, including manufacturing variability, sterilization impacts on polymer integrity, and regulatory evidence expectations across jurisdictions. Secondary sources provided a longitudinal perspective on composition science advances, processing innovations, and clinical adoption patterns.

Analytical techniques included comparative technology assessments to evaluate processing methods such as solvent evaporation, spray-drying, and microfluidic encapsulation; gap analysis to identify operational barriers from lab-scale synthesis to clinical-grade production; and scenario planning to explore the implications of trade policy shifts and regional regulatory variation. Quality controls involved triangulation across multiple data sources and expert validation of key technical assertions to ensure robustness.

Limitations of the methodology are noted candidly: proprietary manufacturing processes and confidential development programs can limit visibility into some supplier capabilities, and ongoing regulatory changes may alter specific approval pathways. Nonetheless, the combined primary and secondary approach provides a comprehensive, evidence-based foundation for the insights and recommendations presented herein.

Concluding synthesis emphasizing integrated technical, operational, and regulatory approaches that determine the successful translation of PLGA innovations

In conclusion, PLGA remains a strategically important biomaterial with broad applicability across devices and delivery systems, and its future relevance will be determined by the ability of developers to integrate material science advances, scalable manufacturing, and proactive regulatory strategies. The interplay of composition ratio, molecular weight, product form, and delivery route creates a rich design space that can be exploited to meet diverse clinical needs, provided that organizations align technical choices with operational capabilities and regional commercialization realities.

Further, external pressures such as evolving trade policies underscore the importance of supply chain agility and cross-functional coordination. Strategic investments in manufacturing flexibility, quality systems, and early regulatory engagement will accelerate translation and reduce program risk. Ultimately, stakeholders that adopt a systems-level perspective-connecting polymer science, process engineering, and clinical strategy-will be best positioned to deliver PLGA-enabled solutions that achieve both clinical impact and commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Growth in long-acting injectable drug delivery platforms using PLGA microspheres
  • 5.2. Expansion of PLGA-based biodegradable scaffold technologies for bone tissue regeneration
  • 5.3. Development of personalized PLGA nanoparticle formulations for targeted oncology therapies
  • 5.4. Adoption of continuous manufacturing techniques for scalable PLGA polymer production
  • 5.5. Integration of PLGA with 3D printing for patient-specific resorbable implants
  • 5.6. Regulatory pathway clarifications accelerating approval of PLGA drug-device combinations
  • 5.7. Sustainability improvements via bio-based monomer sourcing for greener PLGA polymers
  • 5.8. Advances in PLGA surface modification to enhance cell adhesion in regenerative medicine
  • 5.9. Emergence of PLGA encapsulation systems for mRNA vaccine delivery and stability
  • 5.10. Strategic alliances between contract manufacturers and pharma for PLGA delivery solutions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. PLGA Market, by Application

  • 8.1. Cardiovascular Devices
  • 8.2. Drug Delivery
    • 8.2.1. Controlled Release
    • 8.2.2. Sustained Release
    • 8.2.3. Targeted Delivery
  • 8.3. Ophthalmic Devices
  • 8.4. Orthopedic Implants
  • 8.5. Tissue Engineering

9. PLGA Market, by Product Type

  • 9.1. Films
  • 9.2. Implants
  • 9.3. Microspheres
  • 9.4. Nanoparticles
  • 9.5. Sutures

10. PLGA Market, by Composition Ratio

  • 10.1. 50:50
  • 10.2. 65:35
  • 10.3. 75:25

11. PLGA Market, by Molecular Weight

  • 11.1. High
  • 11.2. Low
  • 11.3. Medium

12. PLGA Market, by Delivery Route

  • 12.1. Implantable
  • 12.2. Injectable
  • 12.3. Oral
  • 12.4. Topical

13. PLGA Market, by End Use

  • 13.1. Medical Devices
  • 13.2. Pharmaceutical
  • 13.3. Veterinary

14. PLGA Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. PLGA Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. PLGA Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Evonik Nutrition & Care GmbH
    • 17.3.2. Corbion N.V.
    • 17.3.3. JRS PHARMA GmbH & Co. KG
    • 17.3.4. Jiangsu Huash Biosciences Co., Ltd.
    • 17.3.5. Akina, Inc.
    • 17.3.6. IMS Biotechnology Co., Ltd.
    • 17.3.7. Shenzhen Shelinsen Biotechnology Co., Ltd.
    • 17.3.8. Zhejiang Sobit Biotechnology Co., Ltd.
    • 17.3.9. Feyeo Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLGA MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLGA MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL PLGA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL PLGA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL PLGA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLGA MARKET SIZE, BY COMPOSITION RATIO, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL PLGA MARKET SIZE, BY COMPOSITION RATIO, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLGA MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL PLGA MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PLGA MARKET SIZE, BY END USE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL PLGA MARKET SIZE, BY END USE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PLGA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS PLGA MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL PLGA MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL PLGA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. PLGA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. PLGA MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PLGA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PLGA MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL PLGA MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLGA MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL PLGA MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLGA MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL PLGA MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLGA MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL PLGA MARKET SIZE, BY CARDIOVASCULAR DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL PLGA MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLGA MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL PLGA MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLGA MARKET SIZE, BY CONTROLLED RELEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL PLGA MARKET SIZE, BY CONTROLLED RELEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLGA MARKET SIZE, BY CONTROLLED RELEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL PLGA MARKET SIZE, BY CONTROLLED RELEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLGA MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL PLGA MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLGA MARKET SIZE, BY SUSTAINED RELEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL PLGA MARKET SIZE, BY SUSTAINED RELEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLGA MARKET SIZE, BY SUSTAINED RELEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL PLGA MARKET SIZE, BY SUSTAINED RELEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLGA MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL PLGA MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLGA MARKET SIZE, BY TARGETED DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL PLGA MARKET SIZE, BY TARGETED DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLGA MARKET SIZE, BY TARGETED DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL PLGA MARKET SIZE, BY TARGETED DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLGA MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL PLGA MARKET SIZE, BY OPHTHALMIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLGA MARKET SIZE, BY OPHTHALMIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL PLGA MARKET SIZE, BY OPHTHALMIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLGA MARKET SIZE, BY OPHTHALMIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL PLGA MARKET SIZE, BY OPHTHALMIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLGA MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL PLGA MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLGA MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL PLGA MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLGA MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL PLGA MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLGA MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL PLGA MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLGA MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL PLGA MARKET SIZE, BY TISSUE ENGINEERING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLGA MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL PLGA MARKET SIZE, BY TISSUE ENGINEERING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLGA MARKET SIZE, BY FILMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL PLGA MARKET SIZE, BY FILMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLGA MARKET SIZE, BY FILMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL PLGA MARKET SIZE, BY FILMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL PLGA MARKET SIZE, BY FILMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL PLGA MARKET SIZE, BY FILMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLGA MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL PLGA MARKET SIZE, BY IMPLANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL PLGA MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL PLGA MARKET SIZE, BY IMPLANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLGA MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL PLGA MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLGA MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL PLGA MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL PLGA MARKET SIZE, BY MICROSPHERES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL PLGA MARKET SIZE, BY MICROSPHERES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL PLGA MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL PLGA MARKET SIZE, BY MICROSPHERES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL PLGA MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL PLGA MARKET SIZE, BY NANOPARTICLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLGA MARKET SIZE, BY NANOPARTICLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL PLGA MARKET SIZE, BY NANOPARTICLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL PLGA MARKET SIZE, BY NANOPARTICLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL PLGA MARKET SIZE, BY NANOPARTICLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLGA MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL PLGA MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLGA MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL PLGA MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLGA MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL PLGA MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL PLGA MARKET SIZE, BY 50:50, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL PLGA MARKET SIZE, BY 50:50, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL PLGA MARKET SIZE, BY 50:50, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL PLGA MARKET SIZE, BY 50:50, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL PLGA MARKET SIZE, BY 50:50, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL PLGA MARKET SIZE, BY 50:50, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL PLGA MARKET SIZE, BY 65:35, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL PLGA MARKET SIZE, BY 65:35, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL PLGA MARKET SIZE, BY 65:35, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL PLGA MARKET SIZE, BY 65:35, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL PLGA MARKET SIZE, BY 65:35, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL PLGA MARKET SIZE, BY 65:35, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL PLGA MARKET SIZE, BY 75:25, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL PLGA MARKET SIZE, BY 75:25, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL PLGA MARKET SIZE, BY 75:25, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL PLGA MARKET SIZE, BY 75:25, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL PLGA MARKET SIZE, BY 75:25, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL PLGA MARKET SIZE, BY 75:25, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL PLGA MARKET SIZE, BY HIGH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL PLGA MARKET SIZE, BY HIGH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL PLGA MARKET SIZE, BY HIGH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL PLGA MARKET SIZE, BY HIGH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL PLGA MARKET SIZE, BY HIGH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL PLGA MARKET SIZE, BY HIGH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL PLGA MARKET SIZE, BY LOW, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL PLGA MARKET SIZE, BY LOW, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL PLGA MARKET SIZE, BY LOW, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL PLGA MARKET SIZE, BY LOW, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL PLGA MARKET SIZE, BY LOW, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL PLGA MARKET SIZE, BY LOW, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL PLGA MARKET SIZE, BY MEDIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL PLGA MARKET SIZE, BY MEDIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL PLGA MARKET SIZE, BY MEDIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL PLGA MARKET SIZE, BY MEDIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL PLGA MARKET SIZE, BY MEDIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL PLGA MARKET SIZE, BY MEDIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL PLGA MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL PLGA MARKET SIZE, BY IMPLANTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL PLGA MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL PLGA MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL PLGA MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL PLGA MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL PLGA MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL PLGA MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL PLGA MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL PLGA MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL PLGA MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL PLGA MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL PLGA MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL PLGA MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL PLGA MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL PLGA MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL PLGA MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL PLGA MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL PLGA MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL PLGA MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL PLGA MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL PLGA MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL PLGA MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL PLGA MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL PLGA MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL PLGA MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL PLGA MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL PLGA MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL PLGA MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL PLGA MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL PLGA MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL PLGA MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL PLGA MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL PLGA MARKET SIZE, BY PHARMACEUTICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL PLGA MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL PLGA MARKET SIZE, BY PHARMACEUTICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL PLGA MARKET SIZE, BY VETERINARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL PLGA MARKET SIZE, BY VETERINARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL PLGA MARKET SIZE, BY VETERINARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL PLGA MARKET SIZE, BY VETERINARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL PLGA MARKET SIZE, BY VETERINARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL PLGA MARKET SIZE, BY VETERINARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL PLGA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL PLGA MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS PLGA MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS PLGA MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 287. AFRICA PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 288. AFRICA PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL PLGA MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL PLGA MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 323. GCC PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 324. GCC PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 325. GCC PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. GCC PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 327. GCC PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 328. GCC PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 329. GCC PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. GCC PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. GCC PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 332. GCC PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 333. GCC PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 334. GCC PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 335. GCC PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 336. GCC PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 337. GCC PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 338. GCC PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPEAN UNION PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPEAN UNION PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. EUROPEAN UNION PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 344. EUROPEAN UNION PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 345. EUROPEAN UNION PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. EUROPEAN UNION PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. EUROPEAN UNION PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 348. EUROPEAN UNION PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 349. EUROPEAN UNION PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 350. EUROPEAN UNION PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 351. EUROPEAN UNION PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 352. EUROPEAN UNION PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 353. EUROPEAN UNION PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 354. EUROPEAN UNION PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 355. BRICS PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 356. BRICS PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 357. BRICS PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 358. BRICS PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 359. BRICS PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 360. BRICS PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 361. BRICS PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 362. BRICS PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 363. BRICS PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 364. BRICS PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 365. BRICS PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 366. BRICS PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 367. BRICS PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 368. BRICS PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 369. BRICS PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 370. BRICS PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 371. G7 PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 372. G7 PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 373. G7 PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 374. G7 PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 375. G7 PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 376. G7 PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 377. G7 PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 378. G7 PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 379. G7 PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 380. G7 PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 381. G7 PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 382. G7 PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2025-2032 (USD MILLION)
  • TABLE 383. G7 PLGA MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 384. G7 PLGA MARKET SIZE, BY DELIVERY ROUTE, 2025-2032 (USD MILLION)
  • TABLE 385. G7 PLGA MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
  • TABLE 386. G7 PLGA MARKET SIZE, BY END USE, 2025-2032 (USD MILLION)
  • TABLE 387. NATO PLGA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 388. NATO PLGA MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 389. NATO PLGA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 390. NATO PLGA MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 391. NATO PLGA MARKET SIZE, BY DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 392. NATO PLGA MARKET SIZE, BY DRUG DELIVERY, 2025-2032 (USD MILLION)
  • TABLE 393. NATO PLGA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 394. NATO PLGA MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 395. NATO PLGA MARKET SIZE, BY COMPOSITION RATIO, 2018-2024 (USD MILLION)
  • TABLE 396. NATO PLGA MARKET SIZE, BY COMPOSITION RATIO, 2025-2032 (USD MILLION)
  • TABLE 397. NATO PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 2018-2024 (USD MILLION)
  • TABLE 398. NATO PLGA MARKET SIZE, BY MOLECULAR WEIGHT, 202